E
AMGN icon

Ergoteles’s Amgen AMGN Stock Holding History

Ergoteles’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,658
Closed -$2.82M – 1025
2023
Q1 		$2.82M Sell
11,658
-1,105
-9% -$271K 0.11% 180
2022
Q4 		$3.35M Buy
12,763
+1,510
+13% +$405K 0.12% 169
2022
Q3 		$2.54M Buy
11,253
+6,097
+118% +$1.48M 0.09% 221
2022
Q2 		$1.25M Buy
5,156
+4,250
+469% +$1.04M 0.04% 446
2022
Q1 		$219K Buy
+906
New +$208K 0.01% 954
2021
Q3 		– Sell
-51,697
Closed -$12.6M – 1171
2021
Q2 		$12.6M Buy
+51,697
New +$12.7M 0.29% 102
2021
Q1 		– Sell
-3,668
Closed -$843K – 783
2020
Q4 		$843K Sell
3,668
-21,132
-85% -$4.87M 0.03% 359
2020
Q3 		$6.3M Buy
+24,800
New +$6.14M 0.83% 27

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's AMGN Position: Q2 2023 in Review

Ergoteles sold out of Amgen (AMGN) in Q2 2023, closing a stake of 11,658 shares — an estimated $2.82M sold.

Ergoteles first reported a position in AMGN in Q3 2020 and held it in 8 quarters. The position peaked at $12.6M in Q2 2021. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Ergoteles reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 11,658 Amgen shares in Q2 2023, an estimated $2.82M.
  • Ergoteles first reported a position in Amgen in Q3 2020 and held it in 8 quarters.
  • Ergoteles's Amgen position peaked at $12.6M in Q2 2021.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.